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Distinct trends in 30-day observed and risk-standardized mortality rates of Acute 
Myocardial Infarction Patients, 2005-2010 
Abstract 
 
In the effort of comparing health care quality across hospitals and profiling 
hospitals, the Centers for Medicare and Medicaid Services (CMS) utilize risk-
standardized outcome in which the hospital-level outcome is standardized adjusting for  
patient-covariates using hierarchical model for patients outcome clustered within hospital. 
Even though standardized measure is useful for comparing hospitals, we believe the 
analysis of observed hospital-level outcome without standardization can reveal additional 
information at the hospital-level. The implication of using both types of mortality rates 
was studied in the context of analyzing 30-day mortality trend of Acute Myocardial 
Infarction (AMI) patients. Therefore the objective of this study was 1) describe trend in 
30-day all cause mortality rates of AMI patients, 2) identify groups of hospitals with 
distinct trends and determine patient and hospital characteristics associated with group 
membership, and 3) examine how the risk-standardization approach affects the trajectory 
shape. 
 
During 2005-2010, the 30-day mortality trend of AMI patients showed a 
decreasing trend. The median observed mortality decreased by 4.3% from 18.8% to 
14.5%, but the between-hospital variation remained unchanged.  Five distinct groups of 
hospitals were identified based on their patterns of mortality rate over time. Trajectories 
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using observed rates showed varying trend and level of mortality, whereas all trajectories 
of risk-standardization rates show decreasing trend that is rather smooth with different, 
levels and slope of mortality slightly differed. When using observed rates, 9 patient 
characteristics were associated with group membership including age, history of heart 
failure, chronic atherosclerosis, valvular heart disease, hypertension, pneumonia, 
functional disability, metastatic cancer, and chronic liver disease. For hospital 
characteristics, cumulative AMI volume was the only factor significantly associated (p < 
0.0001). When using risk-standardized rates, 8 patient characteristics associated with 
group membership including age, history of heart failure, history of AMI, chronic 
atherosclerosis, valvular heart disease, COPD, and peripheral vascular disease. For 
hospital characteristics, four covariates including cumulative AMI volume, urban/rural 
classification, proportion of Medicaid patients, and region, were significantly associated 
(p < 0.0001). Lastly, we found that the change in trajectory shape between observed and 







In the past decade, quality improvement of the healthcare system has been an important 
issue in the United States. As Institute of Medicine reported, the US healthcare has been 
“insufficiently safe, effective, patient-centered, efficient, timely, or equitable”. 
(Bielaszka-DuVernay 2011) Therefore there have been significant efforts in 
	   7	  
understanding such deficiencies and factors affecting healthcare quality and 
improvement. For example, one of the well-known factors that expanded understanding 
of the US healthcare was described by the Dartmouth Atlas group. They found that 
geographical location of the health care system is a key factor in leading to differential 
capacity and style of the local health care system. (Wennberg, Cooper et al. 1999) In 
addition, other sources and types of discrepancies and their related outcome have been 
studied.  
 
The Centers for Medicare and Medicaid Services (CMS) is one of the main healthcare 
organizations committed to quality improvement. To assess hospital care quality in 
particular, CMS compares hospital performances via profiling. Profiling is the process of 
“comparing health care provider’s structure, processes of care, or outcomes to a 
normative or community standard”. (Normand and Shahian 2007) It allows evaluating 
healthcare providers such as physicians, hospitals, or provider networks by quantifying 
performances. The performances are quantified by developing performance indices and 
become available to public via a consumer-oriented website called Hospital Compare. It 
provides information on how well hospitals provide care to their patients. This 
information can help patients make informed decisions by allowing them to select and 
compare performance of multiple hospitals for conditions such as heart attack, heart 
failure, pneumonia, and surgery. (Services 2013) 
 
Current statistical approach used for hospital profiling is risk-standardized measure 
obtained using hierarchical generalized linear model. (Keenan, Normand et al. 2008) 
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(Krumholz, Lin et al. 2011) Health care data is typically clustered at multiple levels, such 
as patients, physicians, hospitals, or network providers. A model estimating the hospital-
level outcome needs to take into account both patient- and hospital-level characteristics. 
To accommodate, a multi-level analysis is needed since a patient-level mortality model 
will not sufficiently address clustering of patients and different number of patients in the 
hospital. (Normand, Glickman et al. 1997) Therefore risk-standardization is needed in 
order to fairly assess hospital performance relative to other providers. For example, it is 
expected that mortality rate is higher for the hospitals with sicker patients. Therefore, we 
do not want to penalize the hospitals that treat sicker patients. 
 
Risk-standardization is a two-stage approach designed to simultaneously model both 
patient- and hospital-levels of data using hierarchical regression model. This allows 
variance in patient outcomes both within and between hospitals to be appropriately 
accounted.  To obtain risk standardized mortality rate for hospital, first a patient-level 
regression model is developed to select significant demographic and clinical risk factors 
after backwards elimination. Next the simultaneous modeling occurs: 1) At the patient 
level, the log‐odds of mortality of a binary outcome, such as mortality within 30 days of 
admission, is modeled with patient risk factors and a hospital‐specific intercept. 2) At the 
hospital level, the hospital‐specific intercepts are modeled as normally distributed. Next, 
a hospital-level standardized outcome is determined by calculating the ratio of predicted 
to expected mean mortality multiplied by population-level unadjusted national mean 
mortality (Bernheim, Wang et al. 2012). The predicted mean mortality of a hospital takes 
into the account of the hospital specific intercept while the expected mean mortality does 
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not.  
Therefore, parameter estimates of patient risk-adjustment model are used to calculate 
standardized rate. (Timbie and Normand 2008) However due to aggregation of patient 
information, risk-standardization provides limited insight into the heterogeneity within 
both patient- and hospital-level. In other applications that assess education outcome at 
student- and class-levels, it was shown that the aggregation of student outcome at class 
level caused errors in student outcomes to distort the assessment of the class-level 
construct (Ludtke, 2011). Therefore the information about patient-level variation is 
reduced or lost, and risk-standardization rates of hospitals become more homogeneous. 
Use of risk-standardized rates is necessary for the purpose of hospital profiling. However, 
observed rates also provide insightful information since it gives researchers a sense of 
how hospitals are performing and how the dynamics of patients over time affects the 
hospital trajectory. Therefore this thesis intends to explore such implication of using 
observed and risk-standardized rates in the context of mixture modeling of hospitals 
treating patients with cardiovascular disease. 
 
Acute Myocardial Infarction 
 
Acute Myocardial Infarction (AMI) is a high-risk condition that remains as a leading 
cause of deaths in the United States. (Go, Mozaffarian et al. 2013) With nationwide 
efforts to improve hospital quality of care for patients with cardiovascular diseases, it has 
been shown in a recent study that the short-term mortality rate of AMI patients decreased. 
(Krumholz, Wang et al. 2009) In addition to reduction in overall mortality, the authors 
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found that the between-hospital heterogeneity also decreased. However, it is possible that 
not all hospitals consistently experienced such reduction in the level and rate of mortality. 
In order to identify ways to improve quality of hospital care, it is helpful to describe how 
the trend in mortality of AMI patients and obtain more insight into how differential level 
and rate of mortality is related to patient or hospital characteristics.  
 
Growth Mixture Modeling 
 
Growth mixture modeling (GMM) allows such analysis of trajectories. GMM is a method 
of analyzing developmental trajectories that complements traditional methods including 
hierarchical modeling and latent growth curve modeling. (Jones, Nagin et al. 2001) 
Mixture model assumes the presence of subpopulations an overall population and 
therefore is useful for modeling unobserved heterogeneity in a population. Based on 
multinomial modeling strategy, GMM allows grouping of trajectories with distinct 
pattern. Such partitioning will allows us to see hospitals displaying distinct trend of 
mortality rate of AMI patients. This method has been widely used for social and 
psychological sciences, medical studies, and population-based studies investigating 
differential trajectories. (Jung and Wickrama 2008)  
 
The objectives of this study are three-fold. First we intend to describe nation-wide trend 
in 30-day all-cause mortality rates AMI patients in the United States between 2005 and 
2010 using both observed and risk-standardized rates. We hypothesize that there will be 
multiple groups of hospitals with distinct trajectories in terms of level, rate, and shape. 
Secondly, we will identify hospital characteristics associated with differential trajectory 
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group memberships. It will help better understand factors leading to differential outcome 
and elucidate possible ways to improve hospital care, especially for hospitals that do not 
show a favorable trend. Lastly we intend to explore how patient and hospital covariates 
and hospital-specific random effect involved in the risk-standardization step affects 
trajectory shape. 
Materials and Methods 
	  
Data Source and Study Population 
 
The patient data were obtained from the standard analytics files from the Center for 
Medicare and Medicaid Services. The denominator population is 100% fee-for-service 
Medicare Beneficiaries. The numerator population is Medicare beneficiaries discharged 
with a primary diagnosis of acute myocardial infarction from acute care hospitals from 
January 1, 2005 to December 31, 2010 (ICD-9 code 410.xx (except 410.x2)). The 
inclusion criterion was 65 years old or older who were enrolled in fee-for-service 12-
month prior to the index hospitalization. Exclusion criteria includes same or next day 
discharge when patient did not die or get transferred, transfers into the hospital, In 
hospice within one year prior to including on the day of admission, discharges against 
medical advice, inconsistent or unknown vital status, and unreliable data. Also for the 
2007-2010 period, VA beneficiaries who are added to the analytic files were excluded for 
the analysis. Once initial index cohort was identified, among patients with more than one 
admission in a given year for AMI, only one index admission for AMI was randomly 
selected for inclusion in the cohort. Additionally, hospitals with 5-year cumulative AMI 
volume less than 10 (n=662) and corresponding patients (n=2863) were excluded. The 
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hospital data were obtained from the American Hospital Association Annual Survey 
Database for the fiscal year 2009.  
 
Patient and hospital characteristics 
 
The outcome variable of interest is 30-day all-cause mortality for AMI patients, which is 
defined as death of AMI patients within 30 days of admission for any cause either in or 
outside hospital. The patient covariates considered are two demographic variables (age as 
a continuous variable and sex), eight cardiovascular history variables (history of PTCA, 
CABG, heart failure, AMI, unstable angina, chronic atherosclerosis, cardiopulmonary-
respiratory failure and shock, valvular heart disease). Also 15 comorbidities considered 
are hypertension, stroke, cerebrovascular disease, renal failure, COPD, pneumonia, 
diabetes mellitus, protein-calorie malnutrition, dementia, functional disability, peripheral 
vascular disease, metastatic cancer, trauma in the past year, major psychiatric disorder, 
and chronic liver disease. Lastly, seven hospital characteristics were considered including 
teaching status, geographic location, proportion of Medicaid/ population, urban/rural 
classification, ownership type, total bed count, and cumulative AMI volume during 2005-
2010. 
  
Statistical Method and Analysis 
 
Descriptive statistics (mean and percentages) was calculated to describe sample patient 
and hospital characteristics. Three types of mortality rates were calculated for each 
analytic period: 1) Patient-level mortality rate, which is the proportion of patients died 
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across all hospitals), 2) Hospital-level observed mortality rate (OR), which is the 
proportion of patients died for each hospital), and 3) Hospital-level risk-standardized 
mortality rate (RSR), which is the proportion of patients died for each hospitals adjusted 
for case-mix such as age and comorbidities.  
 
Hierarchical Generalized Linear Model 
 
To account for the natural clustering of observations within hospitals, risk-standardized 
mortality rate was estimated using hierarchical generalized linear model using Proc 
GLIMMIX procedure in SAS. It links the outcome to the risk factors and a hospital-
specific random effect. (Krumholz, Normand et al. 2005) 
 
The following gives the notations for describing the model: 
k: Hospital 
i: Patient 
j: Time period 
 : Probability of each for the ith patient discharged from the kth hospital at time j 
: A vector of patient risk factors 
: Overall intercept for combining all hospitals in the sample at time j 
: Fixed effects coefficients at time j 
: Hospital-specific random effect at time j 
 
The hierarchical model for mortality: 





Next, based on estimated parameters, we calculated a standardized outcome, , for each 
hospital by computing the ratio of the predicted to expected mean outcomes multiplied by 
the unadjusted national mean.  
 
For each j, 
Predicted and expected mortality for patient i in hospital k at time j are given respectively 
as: 
                   and   
nk: Number of patients at hospital k 
 
  
Growth Mixture Modeling 
 
To identify distinct groups of hospitals, growth mixture modeling approach was applied 
to both observed and risk-standardized rates via a SAS macro Proc TRAJ. Assuming that 
the population consists of a mixture of G underlying trajectory groups: 
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g: Trajectory group	  
 = Trajectory of an hospital k =   
 Probability of YK =   
 = Probability of group g membership:  
= Probability of  given group membership in group g: . 
 
The group membership probabilities, , are indirectly estimated by a multinomial logit 
function,  where is normalized to zero for identifiability purposes. 
This method of estimation ensures that each group probability is within the range of 0 
and 1. The form of  was selected based on the type of response variable. For our 
analysis, even though the original source of mortality rate arises from binary outcome of 
death, we considered calculated observed mortality as a continuous variable. Since the 
frequency of mortality rates decrease as the rate increases, the censored normal model 
was chosen as appropriate for modeling these data. The link between mortality rates and 
time is established via a latent variable, , where  and time assume a third-order 
polynomial relationship: .  is 
normally distributed with a zero mean and a constant standard deviation σ. (Jones 2007) 
 
For model selection, the Bayesian Information Criterion (BIC) value was used, which 
favors more parsimonious model. The model with the largest negative BIC value was 
chosen. Reliability of the trajectory was evaluated using average posterior probabilities of 
group membership. It is calculated by averaging the posterior probabilities of individual 
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hospital having been assigned group membership to a trajectory using the maximum 
probability assignment rule. Average posterior probabilities of group membership greater 
than 0.70 to 0.80 indicate that the modeled trajectories group individuals with similar 
patterns of change and discriminate between individuals with dissimilar patterns of 
change. (Andruff, Carraro et al. 2009) 
 
Association between patient and hospital characteristics and group assignment 
 
For both observed and risk-standardized rates, patient and hospital characteristics of 
hospitals in each trajectory group were compared. For patient characteristics, the 
hospital-level proportion of patient risk factor was first computed and averaged within 
each group. Bivariate analyses between a covariate and group membership were 
conducted using Kruskal-Wallis or Chi-square tests. For multivariate association between 
covariates and trajectory group membership, multinomial logistic regression analysis was 
performed. Stepwise selection was performed to determine covariates for the final model. 
Estimates with p < 0.05 were considered statistically significant. We conducted all 
analyses using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). 
 
Comparison of trajectory shapes using observed and risk-standardized rates 
 
Next, we examined factors that cause drastic change in trajectory shapes between 
observed and risk-standardized rates. More specifically, the role of patient covariates, 
hospital covariates, and hospital random effect in trajectory shape was investigated. To 
systematically examine each effect, the hierarchical modeling in the first stage was 
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approached to the following types of mortality rates for each time period and the growth 
mixture modeling was followed, where P represent predicted mortality and E represent 
expected mortality: 
 
Approaches in Hierarchical Modeling of Mortality: 
1) Observed:  Using observed hospital-level mortality rate without regression modeling 
2) E(Intercept + Patient):   Obtaining expected hospital-level mortality rate using only 
patient covariates  
3) E(Intercept + Hospital): Obtaining expected hospital-level mortality rate using only 
hospital covariates  
4) E(Intercept + Hospital + Patient): Obtaining expected hospital-level mortality rate 
using patient and hospital covariates 
5) P(Random Effect + Intercept + Patient): Obtaining predicted hospital-level mortality 
rate using only patient covariates 
6) P(Random Effect + Intercept + Hospital): Obtaining predicted hospital-level mortality 
rate using only hospital covariates 
7) P(Random Effect + Intercept  + Hospital + Patient): Obtaining predicted hospital-level 
mortality rate using only hospital covariates 
8) E(Intercept + Hospital + Patient) / E(Intercept + Patient): Obtaining expected hospital-
level mortality rate using patient and hospital covariates after removing the effect of 
patient covariates, and multiplied by the unadjusted national mean for each time period 
9) E(Intercept + Hospital + Patient) / E(Intercept + Hospital): Obtaining expected 
hospital-level mortality rate using patient and hospital covariates after removing the 
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effect of hospital covariates, and multiplied by the unadjusted national mean for each 
time period 
10) P(Random Effect + Intercept+ Patient) / E(Intercept + Patient) = "RSR": Obtaining 
predicted hospital-level mortality rate using patient covariates divided by the expected 
hospital-level mortality rate using patient covariates, and multiplied by the unadjusted 
national mean for each time period 
11) P(Random Effect + Intercept + Hospital) / E(Intercept + Hospital) : Obtaining 
predicted hospital-level mortality rate using hospital covariates divided by the expected 
hospital-level mortality rate using hospital covariates, and multiplied by the unadjusted 
national mean for each time period 
12) P(Random Effect + Intercept + Hospital + Patient) / E(Intercept + Hospital + Patient) 
: Obtaining predicted hospital-level mortality rate using patient and hospital covariates 
divided by the expected hospital-level mortality rate using patient and hospital covariates, 
and multiplied by the unadjusted national mean for each time period 
Results 
 
Sample patient characteristics 
 
Trends in overall patient characteristics between 2005 and 2010 are described. (Table 1) 
Total number of AMI hospitalizations decreased by 29% from 222,826 to 171,566 
between 2005 and 2010. Demographic characteristics, such as age and proportion of 
males, did not vary. Prevalence of some cardiovascular history and comorbidities 
increased, including history of percutaneous transluminal coronary angioplasty (PTCA), 
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chronic atherosclerosis, cardiopulmonary-respiratory failure and shock, hypertension, 
renal failure, diabetes, protein-calorie malnutrition, peripheral vascular disease, and 
major psychiatric disorders. For some comorbidities, such as valvular heart disease and 
stroke, the proportion decreased. 
 
Table 1. Sample Patient Characteristics 
  No. or % 
Characteristic  2005 2006 2007 2008 2009 2010 
 
Total AMI 
Hospitalization, No. 222826 200843 189075 187642 175497 171566 
Demographic Age (yr) 78.7 78.7 78.9 79.0 78.8 78.8 
 Male 48.9% 49.0% 49.0% 49.8% 50.5% 50.7% 
Cardiovascular History of PTCA 6.9% 7.5% 7.6% 7.8% 7.9% 8.4% 
 History of CABG 6.7% 6.4% 6.2% 6.2% 5.9% 6.0% 
 History of Heart Failure 32.0% 31.2% 31.4% 31.3% 31.2% 30.9% 
 History of AMI 14.0% 13.6% 13.7% 13.6% 13.6% 13.7% 
 
AMI Location - Anterior 
or Anterolateral 11.4% 11.5% 10.7% 9.7% 9.1% 9.0% 
 
AMI Location - 
Inferolateral, 
inferoposterior, inferior, 
other lateral, and true 
posterior 
15.0% 15.2% 14.5% 13.1% 12.9% 12.7% 
 Unstable Angina 14.9% 14.2% 13.8% 13.5% 13.5% 13.2% 
 Chronic atherosclerosis 75.6% 76.0% 76.3% 77.1% 77.4% 77.9% 
 
Cardiopulmonary-
respiratory failure and 
shock 
7.8% 7.8% 8.7% 9.2% 9.3% 9.5% 
 Valvular heart disease 30.0% 31.0% 31.2% 27.3% 26.6% 26.2% 
Comorbid 
conditions Hypertension 78.2% 79.1% 81.7% 83.3% 84.0% 84.7% 
 Stroke 8.7% 8.3% 8.2% 8.3% 8.0% 7.8% 
 Cerebrovascular disease 18.4% 18.7% 19.2% 19.8% 19.8% 19.8% 
 Renal failure 13.2% 16.5% 19.2% 20.5% 21.9% 23.7% 
 COPD 31.0% 30.4% 30.4% 28.7% 28.1% 28.1% 
 Pneumonia 23.9% 23.0% 23.5% 25.0% 24.2% 23.6% 
 Diabetes mellitus 40.2% 40.4% 41.2% 42.1% 42.9% 43.8% 
 
Protein-calorie 
malnutrition 3.6% 3.6% 4.0% 4.9% 5.4% 5.6% 





5.5% 5.3% 5.4% 5.9% 5.8% 6.0% 
	   20	  
 
Peripheral vascular 
disease 23.3% 24.0% 25.0% 25.3% 26.1% 26.4% 
 Metastatic cancer 3.5% 3.6% 3.8% 3.9% 3.9% 3.9% 
 Trauma in past year 27.0% 27.6% 27.9% 27.9% 28.9% 29.4% 
 
Major psychiatric 
disorders 6.4% 6.3% 6.5% 6.9% 7.0% 7.1% 
 Chronic liver disease 0.9% 0.9% 1.0% 1.0% 1.0% 1.1% 
 
 
Sample hospital characteristics 
 
Distribution of hospital characteristics was examined at both hospital- and 
hospitalization-level (Table 2). When analyzed at hospital-level, the majority of hospitals 
was non-teaching (68.9%), private (73.7%), and were located in urban (73.4%), South 
(30.4%) and Midwest (32.4%) regions. Also the hospital sample has an average bed 
count of 187, 5-year cumulative AMI volume of 280, and 17.6% Medicaid patients. 
Analyzed at hospitalization-level, many hospitalizations were performed at non-teaching 
(50.2%), private (86.6%), and were located in urban (93.9%) and in the South (38.7%). 
Also the sample has an average bed count of 367, 5-year cumulative AMI volume of 732, 
and 17.5% Medicaid patients. The discrepancy in distribution at different level of 
analysis indicates disproportionate number of AMI patients in each hospital. 
 











 Number of beds  0-200 2650 62.1 319092 27.8 
 
201-400 877 20.5 419404 36.6 
 
400+ 451 10.6 378528 33.0 
 
Missing 292 6.8 30425 2.7 
Teaching Status No 2944 68.9 575779 50.2 
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Yes 1034 24.2 541245 47.2 
 
Missing 292 6.8 30425 2.7 
Region Northeast 557 13.0 224867 19.6 
 
South 1296 30.4 443888 38.7 
 
Midwest 1384 32.4 294680 25.7 
 
West 694 16.3 148236 12.9 
 
Missing 339 7.9 35778 3.1 
Urban/Rural Urban 3136 73.4 1077549 93.9 
 
Rural 842 19.7 39475 3.4 
 
Missing 292 6.8 30425 2.7 
Ownership Public 832 19.5 123300 10.7 
 
Private 3146 73.7 993724 86.6 
 
Missing 292 6.8 30425 2.7 
AMI volume 
 (5yr Cumulative) 0-25 594 13.9 11220 1.0 
 
26-200 1752 41.0 165079 14.4 
 
201-500 897 21.0 306616 26.7 
 
501-1000 525 12.3 365274 31.8 
 
1001-3000 210 4.9 299260 26.1 
Proportion of 
Medicaid  0-20 2651 62.1 736803 64.2 
 
21-40 1195 28.0 357266 31.1 
 
40+ 132 3.1 22955 2.0 
 
Missing 292 6.8 30425 2.7 
 
Trend in observed- and risk-standardized mortality rates 
 
Trend in observed and risk-standardized mortality rates from 2005 to 2010 were 
examined (Table 3, Figure 1). Over the 6-year period, the 30-day mortality trend of AMI 
patients shows a decreasing trend. The median observed mortality decreased by 4.3% 
from 18.8% to 14.5%. The width of the interquartile range was similar throughout the 
period, meaning the between-hospital variation remained unchanged.  When using 
hierarchical models, the variance for hospital-specific intercepts looks similar across the 
6 years. Mortality showed a decreasing trend even after risk standardization. The median 
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RSR decreased by 3.3% from 19.3% to 16.0%. The width of IQR also remained the same 
throughout the period. 
 
 




Table 3. Trend in observed- and risk-standardized mortality rates, 2005-2010, by 6-
month 
 
    Observed RSR   
Year # Hospitals Mean Median (IQR) Mean  Median (IQR) Population Mortality (Patient-level) 
2005_1 3966 21.9 18.8 (11.8, 27.5) 20.2 19.3 (16.5, 22.9) 18.0 
2005_2 3928 20.7 16.7 (9.5, 26.2) 18.8 17.7 (14.9, 21.5) 16.5 
2006_1 3913 20.7 17.2 (9.8, 27.3) 19.2 18.3 (15.2, 22.0) 16.8 
2006_2 3867 20.4 16.4 (8.6, 25.9) 18.5 17.4 (14.4, 21.2) 16.2 
2007_1 3879 20.5 16.7 (9.1, 26.0) 18.8 17.7 (14.9, 21.5) 16.6 
2007_2 3825 20.8 16.1 (8.3, 25.0) 18.4 17.2 (14.4, 20.9) 16.0 
2008_1 3969 21.5 16.9 (9.3, 27.8) 19.3 18.2 (15.2, 22.2) 16.9 
2008_2 3877 19.6 14.9 (6.9, 25.0) 17.6 16.4 (13.8, 20.2) 15.4 
2009_1 3860 20.5 16.0 (7.8, 25.0) 18.2 16.9 (14.2, 20.9) 16.0 
2009_2 3832 19.9 14.9 (5.9, 25.0) 17.6 16.4 (13.7, 20.2) 15.4 
2010_1 3838 19.7 15.0 (5.9, 25.0) 17.7 16.5 (13.7, 20.5) 15.6 
2010_2 3762 20.2 14.5 (6.3, 25.0) 17.3 16.0 (13.3, 19.8) 15.1 
	   23	  
 
 
Distinct trends in 30-day observed and risk-standardized mortality rates 
 
To find group of hospitals with distinct mortality trajectories between 2005-2010, growth 
mixture modeling was applied to hospital-level observed and risk-standardized mortality 
rates. For RSR trajectory, BIC value peaked at a model using five groups  (Figure 2). 
Based on this result, the five-group model was favored and used for further analyses. 
Therefore we identified five distinct groups of hospitals based on their patterns of 
mortality rate over time.  
 
The shape of trajectories between observed and risk-standardized rates greatly differ 
(Figure 3a, 4a). Five groups of observed rates show dynamic trajectories, with varying 
trend and level of mortality. Using observed groups, Group 3 that includes 87.7% of the 
hospitals shows a trend similar to overall trend in mean observed rates described in 
Figure 1. Two groups (Group 2 and 5) show a sharp increase in average mortality above 
70% in 2007 and 2008, whereas average mortality rates of Group 4 hospitals sharply 
decreased from 50% to below 10%. Also the average posterior probabilities of each 
group assignment ranges from 83.9% to 97.7%, meaning that trajectories are reliable.  
 
On the other hand, all trajectories of risk-standardization rates show decreasing trend and 
all the trajectories look rather smooth, although the level and rates of decrease vary 
across groups. The highest mortality group (Group 3) includes 2.3% of the hospitals with 
average risk-standardized mortality rates of 20% in the first half-year of 2005 to 16% in 
the second half-year of 2010. On the other hand, the lowest mortality group (Group 1) 
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includes 1.0% of the hospitals with average risk-standardized mortality rates of 16.2% in 
the first half-year of 2005 to 14.8% in the second half-year of 2010. The group with 
majority of hospitals (Group 5) includes 87.6% of the hospitals with average risk-
standardized mortality rates of 18.0% in the first half-year of 2005 to 15.8% in the second 
half-year of 2010. 
 
 
Figure 2. BIC Curves for growth mixture model selection 
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Figure 3. A) Distinct patterns of observed mortality rates, 2005-2010; B) Average 
posterior probability table of group assignment 
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Figure 4. A) Distinct patterns of risk-standardized rates, 2005-2010; B) Average 
posterior probability table of group assignment 
 
Group membership between observed- and risk-standardized rates 
 
Distribution of hospitals across trajectory groups was similar for observed and risk-
standardized mortalities (Figure 3b, 4b). For both types of mortality rates, there was one 
group where the majority of hospitals (>86%) were assigned, while remaining hospitals 
were distributed among four other groups. 
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Once hospitals are categorized into groups, an agreement table was created to examine 
how group membership using observed rates change after standardization (Table 4). 
Instead of each group from observed rates remaining distinct, most of the hospitals in the 
four smaller groups (OR Group 1, 2, 4, and 5) folded into the major group (RSR Group 5) 
after standardization. On the other hand, 11.6% of hospitals in the major group (OR 
Group 3) of observed rates dispersed into four smaller distinct groups after risk-
standardization.  
 





Group Membership by Risk-standardized Rate 
1 2 3 4 5 Total 
1 0 0 0 0 91 91 
2 0 0 1 0 110 111 
3 41 278 78 42 3344 3783 
4 0 0 2 2 131 135 
5 0 0 1 0 149 150 
Total 41 278 82 44 3825 4270 
 
Association between patient and hospital characteristics and observed rate group 
assignment 
 
Patient and hospital characteristics of hospitals in each trajectory group were compared. 
To compare patient characteristics, the hospital-level proportion of each patient risk 
factor across all time periods was first computed and averaged for each trajectory group. 
For example, 42.8% of males in Group 1 should be interpreted as the average proportion 
of males among Group 1 hospitals (Table 5). Bivariate analyses between each covariate 
and group membership show that all patient covariates were associated with different 
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group membership (p < 0.0001) except anterior/anterolateral AMI location, hypertension, 
cerebrovascular disease, renal failure, COPD. In multivariate regression analysis, nine 
patient characteristics including age, history of heart failure, chronic atherosclerosis, 
valvular heart disease, hypertension, pneumonia, functional disability, metastatic cancer, 
and chronic liver disease were associated with observed rate group membership (Table 
6). 
 
Hospital characteristics of the each group were similarly compared (Table 7). In bivariate 
analyses, all hospital covariates were associated with group membership (p < 0.0001). 
However in multivariate regression analysis, only cumulative AMI volume was 
significantly associated with group membership of observed rates (p < 0.0001). Number 
of hospital bed was almost significant at p= 0.0531 (Table 8).  
 
Compared to Group 3 that includes 88.6% of hospitals, hospitals with small AMI volume 
were more likely to be in Group 1, 2, 4, and 5 between 2005 and 2010 (Odds ratio = 
0.006, 0.009, 0.024, and 0.061 per increase in 100 hospitalizations) (Table 9). Also 
hospitals with greater number of beds were less likely to be in Group 5 compared to 
Group 3 (Odds ratio = 0.061 per increase in 100 hospitalizations, p = 0.0153). Lastly it is 
worthwhile to note that even though region was not a significant factor in multivariate 
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Table 5. Comparison of patient characteristics (hospital-level average) by observed 
group membership 
 Group 1 Group 2 Group 3 Group 4 Group 5 p-value 
No. of Hospitals (n) 91 111 3783 135 150  
Obs. MR (%) 11.7 37.4 19.3 41.1 33.2 <0.0001 
Age (yr)  81.0 82.8 79.8 82.6 82.6 <0.0001 
Male (%) 42.8 39.0 47.4 41.3 40.9 <0.0001 
AMI Location - Anterior or 
Anterolateral (%) 10.5 9.8 9.2 9.3 8.6 0.1272 
AMI Location - Inferolateral, 
inferoposterior, inferior, other 
lateral, and true posterior  (%) 
9.6 8.7 11.2 9.3 9.3 <0.0001 
History of PTCA (%) 4.4 3.1 6.3 2.8 3.1 <0.0001 
History of CABG (%) 6.2 4.4 6.8 5.5 5.3 <0.0001 
History of Heart Failure (%) 37.4 44.3 35.6 44.6 43.3 <0.0001 
History of AMI (%) 12.8 13.5 13.8 13.4 12.9 0.0119 
Unstable Angina (%) 11.0 12.5 13.6 12.5 11.7 <0.0001 
Chronic atherosclerosis (%) 57.5 54.5 68.7 53.0 55.8 <0.0001 
Cardiopulmonary-respiratory 
failure and shock (%) 7.9 9.0 9.2 9.2 8.7 0.0062 
Valvular heart disease (%) 21.5 21.1 26.6 20.4 21.8 <0.0001 
Hypertension (%) 80.9 82.1 82.4 79.7 81.7 0.0768 
Stroke (%) 7.4 10.5 8.9 10.2 9.4 0.0019 
Cerebrovascular disease (%) 17.6 20.3 19.4 20.5 20.0 0.0852 
Renal failure (%) 19.5 19.3 19.6 19.5 18.3 0.1062 
COPD (%) 29.5 31.9 31.3 31.9 30.8 0.3155 
Pneumonia (%) 27.1 35.0 27.2 36.3 32.3 <0.0001 
Diabetes mellitus (%) 40.4 39.4 42.5 38.6 39.1 <0.0001 
Protein-calorie malnutrition (%) 3.2 4.9 4.6 4.4 3.6 <0.0001 
Dementia (%) 22.4 31.0 21.7 32.8 30.0 <0.0001 
Hemiplegia paraplegia, 
paralysis, functional disability 
(%) 
6.3 8.1 6.4 8.3 8.0 <0.0001 
Peripheral vascular dissease (%) 21.6 23.1 24.6 23.6 23.7 0.0017 
Metastatic cancer (%) 2.2 2.9 3.7 3.0 3.0 <0.0001 
Trauma in past year (%) 30.2 33.2 29.7 35.5 31.8 <0.0001 
Major psychiatric disorders (%) 8.6 10.4 7.9 11.4 11.3 <0.0001 
Chronic liver disease (%) 0.4 0.8 1.0 0.8 1.2 <0.0001 
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Table 6. Patient characteristics associated with observed rate group membership 
(multivariate analysis) 
Patient characteristics P-value 
Age (yr) <.0001 
History of Heart Failure 0.0006 
Chronic atherosclerosis <.0001 
Valvular heart disease <.0001 
Hypertension 0.0275 
Pneumonia 0.0003 
Hemiplegia paraplegia, paralysis, functional disability 0.0145 
Metastatic cancer 0.0090 
Chronic liver disease 0.0022 
 
Table 7. Comparison of hospital characteristics by observed group membership 
  Group 1 Group 2 Group 3 Group 4 Group 5 p-value 
No. of hospitals (n)  91 111 3783 135 150  
No. of beds (mean, n)  69.7 58.6 204.7 55.4 54.8 <0.0001 
Cumulative AMI 
volume (mean, n)  26.5 27.1 314.8 29.2 33.1 <0.0001 
Proportion of 
Medicaid (mean, %)  14.3 13.2 18.0 14.6 14.6 <0.0001 
Teaching Status No (%) 83.5 85.6 66.3 91.1 93.3 <0.0001 
 Yes (%) 8.8 11.7 26.3 7.4 6.0  
 Missing (%) 7.7 2.7 7.4 1.5 0.7  
Region Northeast (%) 44.0 0 14.4 2.2 3.3 <0.0001 
 South (%) 18.7 24.3 31.3 20.0 28.0  
 Midwest (%) 42.9 56.8 29.7 57.8 54.0  
 West (%) 25.3 14.4 16.2 17.8 12.7  
 Missing (%) 8.8 4.5 8.5 2.2 2.0  
Urban/Rural Urban (%) 40.7 45.0 77.3 44.4 42.7 <0.0001 
 Rural (%) 51.6 52.3 15.3 54.1 56.7  
 Missing (%) 7.7 2.7 7.4 1.5 0.7  
Ownership Private (%) 67.9 57.7 75.4 58.5 62.7 <0.0001 
 Public (%) 32.1 39.6 17.2 40.0 36.7  
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Table 8. Hospital characteristics associated with observed rate group membership 
(multivariate analysis) 
Hospital characteristics P-value 
No. of beds (mean, n) 0.0531 
Cumulative AMI volume (mean, n) <.0001 
 
Table 9. Association between hospital characteristics and distinct patterns of 
observed rate 
  Group 1 vs. Group 3 Group 2 vs. Group 3 
 OR 95% CI p-value OR 95% CI p-value 
Cumulative AMI 
Volume1 0.006 0.002 0.024 <.0001 0.009 0.003 0.029 <.0001 
No. of Beds2 1.16 0.86 1.56 0.3351 0.88 0.62 1.25 0.4835 
         
 Group 4 vs. Group 3 Group 5 vs. Group 3 
 OR 95% CI p-value OR 95% CI p-value 
Cumulative AMI 
Volume1 0.024 0.01 0.059 <.0001 0.061 0.03 0.13 <.0001 
No. of Beds2 0.77 0.55 1.09 0.1447 0.63 0.44 0.92 0.0153 
1: The unit for OR effect of cumulative AMI volume is 100 hospitalizations 
2: The unit for OR effect of the number of bed is 100 hospitalizations 
 
 
Association between patient and hospital characteristics and risk-standardized rates group 
assignment 
 
Bivariate analyses between each covariate and group membership show that all patient 
covariates were associated with different group membership (p < 0.0001) except history 
of Coronary Artery Bypass Grafting (CABG), history of AMI, cardiopulmonary-
respiratory failure and shock, cerebrovascular disease, renal failure, and protein-calorie 
malnutrition (Table 10). In multivariate regression analysis, eight patient characteristics 
including age, history of heart failure, history of AMI, chronic atherosclerosis, valvular 
heart disease, COPD, and peripheral vascular disease were associated with RSR group 
membership (Table 11). 
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Hospital characteristics of the each RSR group were similarly compared (Table 12). In 
bivariate analyses, all hospital covariates were associated with group membership (p < 
0.0001). However in multivariate regression analysis, only four covariates including 
cumulative AMI volume, urban/rural classification, proportion of Medicaid patients, and 
region, were significantly associated with group membership of observed rates (p < 
0.0001) (Table 13).  
 
Compared to Group 5 that includes 89.6% of hospitals, all four smaller groups (Group 1, 
2, 3, and 4) were more likely to be urban and have greater cumulative AMI volume 
(Table 14). In addition, Group 1 hospitals were more likely to be located in the Northeast 
(OR=3.38) and have less Medicaid patients (OR=0.44 per 10% increase in proportion of 
Medicaid patients). Group 2 hospitals were less likely to be located in the South 
(OR=0.53, p=0.023) and have less Medicaid patients (OR=0.74 per 10% increase). On 
the other hand, Group 3 and 4 are likely to have more Medicaid patients (OR=1.3 and 
1.26, respectively, per 10% increase). Also Group 4 was more likely to be located in the 
Midwest (OR=2.09) compared to Group 5. 
 
Table 10. Comparison of patient characteristics (hospital-level average) by RSR 
group membership 
 Group 1 Group 2 Group 3 Group 4 Group 5 p-value 
No. of Hospitals (n) 41 278 82 44 3825  
Obs. MR (%) 11.0 12.8 24.0 22.1 21.4 <0.0001 
Age (yr)  78.9 78.9 78.7 78.5 80.2 <0.0001 
Male (%) 51.8 50.2 48.5 49.3 46.2 <0.0001 
AMI Location - Anterior or 
Anterolateral (%) 11.5 10.7 9.1 9.1 9.1 <0.0001 
AMI Location - Inferolateral, 
inferoposterior, inferior, other 
lateral, and true posterior  (%) 
15.8 14.6 12.4 12.3 10.6 <0.0001 
History of PTCA (%) 9.0 7.8 6.7 8.2 5.7 <0.0001 
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History of CABG (%) 5.6 5.8 6.4 7.5 6.7 0.0577 
History of Heart Failure (%) 28.8 30.5 33.9 33.7 37.0 <0.0001 
History of AMI (%) 13.2 13.9 13.6 14.2 13.7 0.6316 
Unstable Angina (%) 14.6 14.2 14.8 15.6 13.3 <0.0001 
Chronic atherosclerosis (%) 83.4 78.8 74.6 76.0 65.9 <0.0001 
Cardiopulmonary-respiratory 
failure and shock (%) 7.5 8.9 8.9 8.9 9.2 0.1154 
Valvular heart disease (%) 33.7 29.9 26.5 27.6 25.6 <0.0001 
Hypertension (%) 81.0 81.2 81.8 82.5 82.3 0.0006 
Stroke (%) 7.7 8.1 9.1 9.0 9.1 0.0041 
Cerebrovascular disease (%) 19.1 19.3 19.1 18.9 19.4 0.9857 
Renal failure (%) 17.6 18.8 19.1 19.5 19.6 0.3028 
COPD (%) 24.5 28.3 31.9 30.5 31.6 <0.0001 
Pneumonia (%) 20.2 23.5 25.3 25.3 28.4 <0.0001 
Diabetes mellitus (%) 39.4 40.7 45.1 43.6 42.2 0.0001 
Protein-calorie malnutrition (%) 3.8 4.4 4.7 4.7 4.6 0.1404 
Dementia (%) 14.8 17.5 19.9 18.0 23.1 <0.0001 
Hemiplegia paraplegia, 
paralysis, functional disability 
(%) 
4.9 5.4 6.0 6.2 6.7 <0.0001 
Peripheral vascular disasese (%) 27.7 25.7 23.8 24.1 24.3 0.0013 
Metastatic cancer (%) 4.2 3.8 3.6 3.6 3.6 0.001 
Trauma in past year (%) 28.3 28.2 28.0 28.0 30.3 <0.0001 
Major psychiatric disorders (%) 6.5 6.9 6.6 7.0 8.4 <0.0001 














	   34	  
Table 11 . Patient characteristics associated with RSR group membership 
(multivariate analysis) 
Patient characteristics P-value 
Age (yr) 0.0051 
History of Heart Failure (%) <.0001 
History of AMI (%) 0.0013 
Chronic atherosclerosis (%) <.0001 
Valvular heart disease (%) <.0001 
COPD (%) <.0001 
Diabetes mellitus (%) <.0001 
Peripheral vascular disease (%) <.0001 
 
 
Table 12. Comparison of hospital characteristics by RSR group membership 
  Group 1 Group 2 Group 3 Group 4 Group 5 p-value 
No. of hospitals (n)  41 278 82 44 3825  
No. of beds (mean, n)  554.7 379.3 273.0 335.0 164.9 <0.0001 
Cumulative AMI 
volume (mean, n)  1338.1 782.8 436.1 529.4 224.3 <0.0001 
Proportion of 
Medicaid (mean, %)  13.9 16.0 20.7 20.6 17.6 <0.0001 
Teaching Status No (%) 29.3 44.2 58.5 54.6 71.6 <0.0001 
 Yes (%) 68.3 53.2 32.9 40.9 21.3  
 Missing (%) 2.4 2.5 8.5 4.6 7.2  
Region Northeast (%) 48.8 24.1 7.3 9.1 12.0 <0.0001 
 South (%) 31.7 35.6 25.6 27.3 30.1  
 Midwest (%) 12.2 20.1 30.5 43.2 33.4  
 West (%) 4.9 17.6 20.7 11.4 16.2  
 Missing (%) 2.4 2.5 15.9 9.1 8.2  
Urban/Rural Urban (%) 97.6 97.1 86.6 90.9 71.0 <0.0001 
 Rural (%) 0.0 0.4 4.9 4.6 21.8  
 Missing (%) 2.4 2.5 8.5 4.6 7.2  
Ownership Private (%) 97.6 89.9 79.3 68.2 72.2 <0.0001 
 Public (%) 0.0 7.6 12.2 27.3 20.6  
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Table 13. Hospital characteristics associated with RSR group membership 
(multivariate analysis) 
Hospital characteristics P-value 
Urban/Rural 0.0024 
Cumulative AMI volume (mean, n) <0.0001 




Table 14. Association between hospital characteristics and distinct patterns of risk-
standardized rate 
  RSR Group 1 vs. Group 5 RSR Group 2 vs. Group 5 
  OR 95% CI p-value OR 95% CI p-value 
Northeast vs. West 3.38 0.74 15.37 <.0001 0.93 0.61 1.42 0.0138 
South vs. West 0.53 0.11 2.67 0.1388 0.53 0.36 0.79 0.023 
Midwest vs. West 0.34 0.06 1.98 0.0262 0.44 0.29 0.69 0.0009 
Urban vs. Rural >999.9* <0.001 >999.9 0.9557 23.1 3.2 166.8 0.0018 
Cumulative AMI 
Volume1 1.56 1.46 1.66 <0.0001 1.33 1.29 1.38 <0.0001 
Prop. Of Medicaid2  0.44 0.26 0.72 0.0013 0.74 0.62 0.88 0.0007 
         
  RSR Group 3 vs. Group 5 RSR Group 4 vs. Group 5 
  OR 95% CI   p-value OR 95% CI   p-value 
Northeast vs. West 0.37 0.14 0.95 0.0839 0.77 0.20 2.92 0.3448 
South vs. West 0.56 0.29 1.10 0.5421 1.00 0.34 2.94 0.6879 
Midwest vs. West 0.82 0.44 1.56 0.2218 2.09 0.76 5.71 0.0155 
Urban vs. Rural 2.8 0.96 7.9 0.0599 6.7 0.88 50.7 0.0662 
Cumulative AMI 
Volume1 1.19 1.12 1.27 <0.0001 1.23 1.15 1.31 <0.0001 
Prop. Of Medicaid2  1.3 1.05 1.6 0.0162 1.26 0.94 1.69 0.1166 
* OR cannot be computed due to quasi-separation of the data 
1: The unit for OR effect of cumulative AMI volume is 100 hospitalizations 
2: The unit for OR effect of the proportion of Medicaid patients is 10%  
 
Comparison of trajectory shapes using observed and risk-standardized rates 
 
The role of patient covariates, hospital covariates, and hospital random effect in trajectory 
shape during risk-standardization step was investigated. As seen in Figure 3, trajectories 
using observed and risk-standardized rates are very different in terms of overall shape, 
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level, and slope. We intend to identify the factors used in hierarchical model that make 
RSR trajectory lose the patient dynamics. By using estimated mortalities  based on 
patient characteristics alone in the first stage for the growth mixture model in the second 
stage, the hospital dynamic of mortality over time was preserved as in the observed 
mortality rates (Figure 5-2). So whether or not to use patient covariates for estimating 
mortality does not seem to significantly affect the shape of the hospital trajectories.  
However, when using estimated mortalities based on hospital characteristics alone, the 
patient dynamic over time is lost and trajectories become similar to those from risk-
standardized rates (Figure 5-3). Figure 5-8 depicts when mortalities are estimated from 
both patient and hospital covariates and standardized by expected mortality from patient 
covariates alone. In this case, standardization step removes the effect of patient 
covariates, but this is not the reason that the  dynamics of hospital trajectory disappears 
and becomes similar to the graph of risk-standardized rates; it is the use of hospital 
covariates that made the dynamic start disappearing. For non-standardized rates, adding 
hospital random effects to each of three types of mortalities caused migration of some 
hospitals to a different group, but did not significantly alter trajectory shape (Figure 5-5, 
5-6, 5-7). Therefore we find that hospital covariate is one of the components of the 
standardization step that drive trajectories become smoother over time. 
 










Figure 5. Change in trajectory shape upon varying fixed effects, random effects, and 
standardization step. Note: for Figure 5-12), growth mixture modeling was not able 




We analyzed trends in 30-day mortality of AMI patients between 2005-2010 and identify 
five groups of hospitals with distinct trends. However, using two types of mortality rates 
– observed and risk-standardized rates, the mortality level and shapes of trajectories 
greatly differed. Also, the hospitals in each trajectory group did not remain in their 
respective group after standardization but instead folded into the group that includes the 
majority of the hospital. Such phenomenon can be explained by the use of shrinkage 
estimator in the risk-standardization step. The shrinkage estimator incorporates the effect 
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of shrinkage by calculating weighted average of the unshrunk estimator of each hospital 
and the average mortality rate of all hospitals, where the weight is determined by sample 
size and within- and between-hospital variance. Therefore, the shrinkage estimator will 
be close to the unshrunk estimator of each hospital if the sample is large or close to the 
grand mean when a hospital has a small sample size and precise estimation of unshrunk 
estimator is not possible (Mukamel, Glance et al. 2010). Indeed all four smaller groups of 
distinct observed mortality trend had a low AMI volume of around 20. However after 
standardization they were folded into the group that includes the majority of the hospital 
with mean mortality close to the population-level average. 
 
AMI volume was the only hospital factor associated with group membership based on 
observed hospital mortality rates whereas four hospital factors such as AMI volume, 
urban/rural classification, the proportion of Medicaid patients, and region were 
significantly associated with group membership of distinct risk-standardized trends. 
These are hospital factors that were previously found to be associated with hospital 
performance. For example, a 2010 study found that increased hospital AMI volume was 
associated with lower 30-day risk-standardized mortality rate of patients with AMI (Ross, 
Normand et al. 2010). Also our finding that 48.8% of the hospitals in the group with 
lowest risk-standardized rate (RSR Group 1) were located in the Northeast is consistent 
with a 2009 study that reduced AMI mortality was found in small, densely populated 
hospital referral regions primarily in the Northeast. (Krumholz, Merrill et al. 2009) Lastly 
we did not find that ownership of the hospital was significantly associated in neither 
observed nor risk-standardized membership. A previous study also showed that the 
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mortality outcome did not vary between public and for-profit hospitals. (Sloan, Trogdon 
et al. 2003) 
 
In conclusion, the trend in 30-day mortality of AMI patients were modeled using both 
observed and risk-standardized rates. For both types of mortality, shape and level of 
trajectories and hospital characteristics associated with group membership were 
drastically different. Examination of standardization components shows that it is the 
adjustment of hospital covariates that causes the smoothing of the trajectory, and not the 
patient covariates. The distinction and common feature between hospital covariates and 
hospital random effects need to be investigated further. 
Appendix 
 
Note: The following codes are courtesy of Dr. Shu-Xia Li at the Yale Center for 
Outcomes Research and Evaluation 
	  




 data temp; 
  set hq.hglm_6m(where=(time_h=&i)); 
 run; 
 
 proc glimmix data=temp; 
  class prov_num_en /*hosp*/; 
  model obs30 = age &pat /*&hosp*//D=B LINK=LOGIT SOLUTION 
oddsratio s; 
  random int/subject=prov_num_en s; 
  random _residual_; 
 
 OUTPUT OUT = go1.glimmix_outPred_&i 
   PRED(BLUP ILINK)=PREDPROB PRED(NOBLUP ILINK)=EXPPROB; 
 
   ods  output ParameterEstimates=go1.glimmix_param_&i; 
   ods  output SolutionR=go1._solnr_&i; 
   ods  output CovParms=go1._cov_&i;  
  NLOPTIONS TECH=NMSIMP; 
 run; 
 
 proc datasets lib=work; 





 %do j=1 %to &time; 
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%macro calculate_RSMR(ds, unit, y, time); 
 %local rawr; 
 %let rawr = ; 
 proc sql noprint; 
   select mean(&y) into :rawr 
   from &ds; 
 quit; 
 
 PROC SQL; 
  CREATE TABLE dsout&time AS 
  SELECT DISTINCT &unit, MEAN(&y) AS OBS&time, 
   MEAN(PREDPROB) AS PRED&time, 
   MEAN(EXPPROB) AS EXP&time, 
   (CALCULATED PRED&time)/(CALCULATED EXP&time) AS 
SR&time, 
   (CALCULATED SR&time)*&rawr AS RSMR&time, 
   COUNT(&unit) AS VOLUME&time 
  FROM &ds 





 %do i=1 %to 12; 
  data ds&i; 
   set go1.glimmix_outpred_&i; 
  run; 
 
  %calculate_RSMR(ds&i, prov_num_en, obs30, %eval(&i)); 
 %end; 
 
 data &dsout(drop=i); 
  merge dsout1 - dsout12; 
  array ts(12) t1 - t12; 
  by prov_num_en; 
  do i = 1 to 12; 
   ts(i) = i; 
  end; 
 run; 
 
 proc datasets lib=work nolist; 






%macro group_vote_prb(grps, grp_prbs, tempds); 
 
 data temp; 
  set &tempds; 
  array grp_prb (&grps) &grp_prbs; 
  do i = 1 to &grps; 
   if i = group then  
   prb = grp_prb(i); 
  end; 
 run; 
  
 proc means data=temp mean median std; 
  class group; 
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/***Growth Mixture Modeling***/ 
 
%macro gmm(i); 
 proc traj data=hq.RSMR_by_6m outplot=gs.op&i outstat=gs.os&i 
out=gs.of&i outest=gs.oe&i; 
  id prov_num_en; 
  var rsmr1 - rsmr12; 
  indep t1 - t12; 
  model cnorm; 
  min 0; 
  max 100; 
  ngroups &i; 
 run; 
 %trajplot (gs.op&i, gs.os&i, "AMI Mortality Rate, 2005-2010", 




 %do numgrp=5 %to 5; 
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